Zhongyi Pharma clinches South Korean GMP
Shanghai. March 28. INTERFAX-CHINA - Tianjin Zhongyi Pharmaceutical Co. Ltd., a traditional Chinese medicine (TCM) maker, has won Good Manufacturing Practice (GMP) certification from South Korea's Food and Drug Administration, a company representative told Interfax March 28.
The company obtained certification for its granule and extract workshops, said the representative, surnamed Zhao.
According to Zhao, Zhongyi Pharma is the first domestic TCM manufacturer to pass South Korean GMP inspections, and the certification will boost the company's exports to the country.
The firm had to improve fingerprints and quality checks for raw TCM materials to win certification. Fingerprinting is a method used to give a breakdown of the constituent ingredients of raw TCM materials.
Zhongyi Pharma was set up in 1993 by Tianjin University of Traditional Chinese Medicine, and manufactures over 70 TCM products. Its major products include ginseng extract, dry liquid extract of Radix Cutellariae, or Baical Skullcap root, and dandelion granules. The company exports to countries including Japan and South Korea.
- KZ